Brevan Howard Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$722K	Buy	33,170 +21,363	+181%	+$413K	0.01%	1090
2025 Q4	$254K	Sell	11,807 -25,604	-68%	-$540K	﹤0.01%	1456
2025 Q3	$721K	Buy	+37,411	New	+$667K	0.01%	1081
2025 Q2	–	Sell	-7,869	Closed	-$502K	–	2016
2025 Q1	$502K	Buy	7,869 +2,884	+58%	+$304K	0.01%	729
2024 Q4	$606K	Buy	4,985 +1,339	+37%	+$164K	0.02%	564
2024 Q3	$455K	Sell	3,646 -431	-11%	-$59.6K	0.02%	707
2024 Q2	$644K	Sell	4,077 -6,635	-62%	-$852K	0.04%	526
2024 Q1	$1.39M	Buy	10,712 +2,653	+33%	+$325K	0.13%	199
2023 Q4	$777K	Buy	8,059 +6,184	+330%	+$593K	0.08%	316
2023 Q3	$227K	Buy	+1,875	New	+$212K	0.07%	301